Orchid Chemicals & Pharmaceuticals
Orchid sells API, R&D unit to Hospira for Rs1,113 crore to reduce debt
30 Aug 2012
The businesses sold accounted for around 23 per cent of the total sales of the company last year
Orchid shuts Alathur plant on pollution concerns
12 Jul 2011
Hospira of US buys Orchid’s injectables business
16 Dec 2009
Orchid has 54 products for launch in the US, has also filed about 72 marketing applications to supply active pharmaceutical ingredients.
